Novel Synthesis of Cholesterol
AISimple SummaryContent extracted from patent full text and abstract with AI.
This patent discloses a novel chemical method for synthesizing cholesterol from plant-derived diosgenin instead of traditional animal sources. The process involves protecting specific groups on diosgenin, opening certain rings in its structure, activating and reducing intermediates, and ultimately producing pure cholesterol. The method improves upon existing technologies by using renewable plant materials and producing less waste.
Use CasesContent extracted from patent full text and abstract with AI.
- Industrial-scale production of cholesterol for pharmaceuticals, cosmetics, and food supplementation.
- Synthesis of steroid hormones and vitamin D precursors for medical and research applications.
- Manufacture of cholesterol-containing drug delivery systems, such as lipid nanoparticles for vaccines.
- Reduction of dependency on animal-derived cholesterol in various industries, increasing vegan/vegetarian-compatible products.
- Production of cholesterol in regions with restrictions on animal-derived products or concerns about animal-borne contaminants.
BenefitsContent extracted from patent full text and abstract with AI.
- Provides a sustainable and ethical alternative to animal-sourced cholesterol, reducing reliance on livestock and minimizing environmental impact.
- Reduces risk of contamination by animal-borne pathogens such as prions.
- Produces cholesterol with high purity and yield, improving process efficiency and lowering manufacturing costs.
- Generates less industrial waste compared to traditional extraction methods from animal tissues.
- Enables consistent and scalable cholesterol production independent of animal agriculture and global livestock supply fluctuations.
Technical Classifications (CPCs)
Main Classifications
Chemistry & Materials Science
Sub Classifications
Organic Chemistry
CPC Codes
Inventors & Applicants
Applicants
Cordenpharma Int Gmbh
Univ Otto von Guericke Magdeburg
Patent Abstract
The invention relates to a synthesis of cholesterol; a ring opening step of the compound of formula (I)and subsequent activation and reduction step yielding cholesterol. The inventions relates also to intermediates achieved during said synthesis.
Key Information
Publication No.
EP4089100A1
Family ID
75936712
Publication Date
2022-11-16
Application No.
EP21173824A
Application Date
2021-05-14
Priority Date
2021-05-14
Granted
No
Possible Cooperation
For further information please contact the transfer office.